Scholarships honor exceptional scholars in PhD programs.

Threat of a pandemic remains low, but international collaboration is needed to contain the virus, DGHI expert says.

Executive Vice President for Health Affairs and Dean of the Duke University School of Medicine Mary Klotman, MD, talks with Robert Tighe, MD, about the school’s new climate change research strategy, emphasizing the critical need to address the climate crisis and its impact on health.

Stacy Waters, MBA, has been named the new vice president of Duke Health Development and Alumni Affairs (DHDAA), effective November 4, 2024.  

Ryan Antiel , MD, has been awarded a Greenwall Faculty Scholars Award for his work on the ethics of artificial womb technology.

A study from the Duke Department of Pharmacology and Cancer Biology reveals why higher levels of testosterone cause early prostate cancers to grow but can stop later-stage disease. The findings promise to help doctors better target treatment.

NIH Method to Extend Research in Time (MERIT) Award supports research of the immune evasion strategies of Chlamydia trachomatis, the most common sexually transmitted bacterial infection.

By analyzing their spike proteins, Duke researchers reveal how the Omicron XBB variants balance stability, receptor usage and immune evasion.

Debra Silver, PhD, professor of molecular genetics and microbiology, cell biology and neurobiology at Duke University School

The Duke Human Vaccine Institute has received funding from the National Institutes of Health to manufacture H5N1 avian flu vaccines for use in clinical trials.